intracellular
bacteri
viral
pathogen
evolv
numer
mechan
appropri
exploit
differ
system
host
life
cycl
order
facilit
spread
entri
exit
host
cudmor
et
al
finlay
cossart
dramsi
cossart
case
virus
perhap
best
studi
exampl
exploit
actin
cytoskeleton
vaccinia
viru
exit
infect
cell
cudmor
et
al
vaccinia
viru
larg
dna
viru
genom
kb
encod
open
read
frame
orf
close
rel
variola
viru
caus
agent
smallpox
johnson
et
al
massung
et
al
vaccinia
viru
morphogenesi
complex
process
occur
cytoplasm
infect
cell
result
format
intracellular
matur
viru
imv
intracellular
envelop
viru
iev
imv
consist
viral
core
dna
protein
envelop
membran
cisterna
deriv
intermedi
compart
sodeik
et
al
imv
core
contain
five
major
protein
vanslyk
hrubi
jensen
et
al
protein
associ
membran
around
viru
particl
jensen
et
al
betakova
et
al
depend
viru
strain
cell
type
proport
imv
becom
enwrap
membran
cisterna
deriv
transgolgi
apparatu
give
rise
iev
particl
schmelz
et
al
date
six
ievspecif
protein
roper
et
al
duncan
smith
parkinson
smith
payn
norrbi
shida
engelstad
et
al
isaac
et
al
hirt
et
al
identifi
studi
use
recombin
virus
shown
play
import
role
iev
assembl
blasco
moss
engelstad
smith
wolff
et
al
roper
et
al
sanderson
et
al
et
al
vaccinia
viru
thought
leav
cell
fusion
outer
iev
membran
plasma
membran
give
rise
extracellular
envelop
viru
eev
morgan
payn
blasco
moss
cellassoci
envelop
virus
cev
remain
associ
outer
surfac
plasma
membran
blasco
moss
complex
vaccinia
infect
process
actin
cytoskeleton
dramat
reorgan
numer
actin
cometlik
tail
induc
iev
particl
cudmor
et
al
et
al
use
actin
polymer
drive
forc
iev
particl
propel
actin
tail
contact
plasma
membran
extend
outward
therebi
facilit
infect
neighbour
cell
cudmor
et
al
addit
vaccinia
infect
result
stimul
cell
motil
loss
contact
inhibit
chang
cell
adhes
sanderson
smith
sanderson
et
al
vaccinia
virusinduc
cell
motil
subdivid
cell
migrat
extens
neuritelik
project
latter
depend
microtubul
sanderson
et
al
depend
neuritelik
project
format
microtubul
suggest
microtubul
cytoskeleton
may
also
play
role
life
cycl
vaccinia
viru
inde
recent
vaccinia
protein
microtubul
shown
requir
effici
imv
dispers
sanderson
et
al
furthermor
absenc
vaccinia
actinbas
motil
cell
cell
spread
still
occur
although
less
effici
wolff
et
al
sanderson
et
al
suggest
addit
transport
mechan
must
exist
given
observ
wonder
whether
microtubul
cytoskeleton
function
life
cycl
vaccinia
viru
report
microtubul
cytoskeleton
complex
play
import
role
earli
stage
vaccinia
infect
howev
later
infect
cycl
loss
centrosom
function
accumul
viralencod
microtubuleassoci
protein
map
result
dramat
rearrang
microtubul
cytoskeleton
indirect
immunofluoresc
label
show
h
postinfect
major
vaccinia
viru
particl
concentr
area
coincid
centr
microtubul
aster
figur
c
examin
whether
local
inde
microtubul
depend
infect
cell
pretreat
nocodazol
depolymer
microtubul
absenc
microtubul
viru
particl
distribut
throughout
cytoplasm
figur
accumul
viru
particl
area
around
centr
microtubul
aster
suggest
microtubul
minu
enddirect
motor
may
involv
establish
posit
viru
locat
examin
possibl
infect
cell
overexpress
act
dominantneg
function
echeverri
et
al
found
cell
overexpress
viru
particl
accumul
centr
microtubul
aster
rather
throughout
cytoplasm
occur
absenc
microtubul
compar
figur
figur
vaccinia
morphogenesi
involv
wrap
host
membran
possibl
effect
nocodazol
viru
local
fact
due
disrupt
intermedi
compart
golgi
apparatu
reagent
burkhardt
et
al
howev
two
independ
experi
show
case
first
cell
infect
absenc
microtubul
golgi
apparatu
well
vaccinia
viru
particl
dispers
throughout
cytoplasm
coloc
figur
secondli
vaccinia
particl
remain
vicin
microtubuleorgan
centr
mtoc
golgi
microtubul
disrupt
treatment
brefeldin
figur
p
similar
result
obtain
use
marker
vaccinia
galactosyltransferas
golgi
intermedi
compart
data
shown
taken
togeth
data
indic
microtubul
cytoskeleton
requir
local
newli
assembl
viru
particl
vicin
mtoc
vaccinia
infect
given
requir
microtubul
vaccinia
local
subsequ
examin
whether
local
role
morphogenesi
two
differ
intracellular
form
vaccinia
viru
imv
iev
electron
microscop
examin
cell
infect
presenc
nocodazol
becam
clear
imv
particl
morpholog
indistinguish
control
form
figur
although
imv
particl
assembl
absenc
microtubul
wonder
whether
number
reduc
whether
form
infecti
sinc
integr
intermedi
compart
depend
microtubul
burkhardt
et
al
address
question
three
independ
viru
stock
prepar
presenc
absenc
nocodazol
simplifi
interpret
data
use
recombin
vaccinia
viru
mutant
unabl
form
iev
blasco
moss
final
concentr
viru
particl
produc
determin
method
joklik
particlesml
presenc
microtubul
particlesml
absenc
microtubul
although
decreas
number
viru
particl
form
absenc
microtubul
particl
form
infecti
data
shown
infecti
imv
form
absenc
microtubul
found
evid
iev
format
base
electron
microscop
examin
cell
infect
presenc
nocodazol
figur
howev
observ
imv
particl
partial
wrap
transgolgi
membran
probabl
process
abort
iev
format
figur
given
data
examin
indirect
immunofluoresc
whether
low
amount
iev
particl
form
absenc
microtubul
howev
could
find
evid
coloc
iev
protein
marker
vaccinia
particl
form
presenc
nocodazol
figur
also
found
evid
iev
format
base
abil
nucleat
actin
tail
figur
iev
particl
assembl
involv
wrap
golgi
apparatu
schmelz
et
al
examin
effect
disrupt
membran
compart
use
brefeldin
could
find
evid
iev
format
base
coloc
iev
protein
marker
viru
particl
actin
tail
cell
infect
presenc
brefeldin
figur
inde
brefeldin
atreat
cell
iev
membran
protein
requir
assembl
observ
endoplasm
reticulum
transgolgi
figur
summari
data
indic
microtubul
cytoskeleton
requir
effici
imv
assembl
essenti
iev
format
cours
experi
becam
obviou
golgi
apparatu
becom
progress
dispers
infect
coconcominantli
disrupt
microtubul
network
figur
analysi
show
infect
normal
morpholog
microtubul
cytoskeleton
replac
morpholog
aberr
microtubul
form
vari
among
common
absenc
discret
mtoc
figur
aberr
form
broadli
classifi
three
type
cell
disorgan
microtubul
network
microtubul
seem
randomli
orient
figur
ii
cell
microtubul
form
ring
around
nucleu
throughout
cytoplasm
figur
iii
cell
long
project
consist
microtubul
bundl
figur
quantifi
appear
differ
morpholog
form
five
independ
infect
experi
cell
count
time
point
experi
figur
f
l
small
compact
cell
repres
h
postinfect
respect
microtubul
cytoskeleton
morpholog
evid
includ
analysi
alreadi
h
postinfect
viru
particl
assembl
occur
normal
aster
microtubul
configur
disrupt
replac
major
cell
microtubul
without
obviou
organ
mtoc
figur
furthermor
cell
microtubul
ring
cell
long
project
time
point
figur
l
infect
proce
microtubul
becom
progress
disrupt
bundl
figur
l
observ
seem
obviou
connect
disrupt
chang
actin
microtubul
cytoskeleton
figur
moreov
reorgan
microtubul
network
occur
cell
infect
vaccinia
delet
mutant
make
actin
tail
data
shown
effect
vaccinia
viru
infect
reorgan
microtubul
cytoskeleton
also
observ
cell
line
examin
swiss
vari
degre
data
shown
data
show
vaccinia
infect
result
sever
disrupt
normal
morpholog
microtubul
cytoskeleton
format
microtubul
bundl
loss
organ
mtoc
vacciniainfect
cell
strongli
reminisc
phenotyp
observ
cell
overexpress
map
weisshaar
et
al
togel
et
al
overexpress
map
stabil
microtubul
examin
whether
microtubul
cytoskeleton
infect
cell
resist
depolymer
nocodazol
cold
treatment
figur
inde
case
suggest
viru
genom
may
encod
viral
protein
maplik
properti
identifi
viral
protein
exhibit
microtubulebind
properti
perform
microtubul
cosediment
assay
use
extract
prepar
uninfect
vacciniainfect
cell
figur
initi
experi
howev
reveal
intact
viru
particl
extract
prone
pellet
even
absenc
microtubul
make
identif
viral
map
imposs
avoid
problem
prepar
extract
cell
infect
presenc
rifampicin
drug
inhibit
vaccinia
viru
particl
assembl
affect
viral
protein
express
moss
et
al
tan
mcauslan
morpholog
effect
vaccinia
infect
microtubul
cytoskeleton
presenc
absenc
rifampicin
data
shown
comparison
protein
present
pellet
microtubul
cosediment
assay
reveal
number
addit
promin
minor
band
present
extract
prepar
vacciniainfect
uninfect
cell
figur
cosediment
assay
perform
presenc
nocodazol
coldtreat
extract
reveal
major
addit
band
disappear
absenc
microtubul
identifi
viral
protein
cosedi
microtubul
perform
ingel
proteas
digest
follow
analysi
result
peptid
maldi
mass
spectrometri
use
approach
identifi
number
potenti
vacciniaencod
map
structur
protein
dnabind
protein
associ
viral
core
vanslyk
hrubi
jensen
et
al
klemper
et
al
conserv
poxviru
genom
unknown
function
figur
use
avail
antibodi
examin
local
infect
cell
see
whether
associ
microtubul
vivo
addit
essenti
role
viru
core
vanslyk
hrubi
jensen
et
al
neg
control
also
examin
local
core
protein
identifi
promin
kda
protein
pellet
absenc
microtubul
figur
indirect
immunofluoresc
analysi
show
associ
microtubul
presenc
absenc
rifampicin
figur
expect
also
associ
viral
particl
data
shown
contrast
never
observ
associ
microtubul
regardless
fixat
condit
local
viral
factori
viral
particl
respect
data
shown
interestingli
associ
microtubul
coloc
subset
acetyl
microtubul
figur
associ
viru
particl
microtubul
rais
question
whether
role
microtubulebind
activ
infect
wonder
whether
two
protein
mediat
interact
incom
viral
core
microtubul
begin
infect
core
viru
particl
releas
cytoplasm
start
infect
cycl
ichihashi
vanderpasschen
et
al
pedersen
et
al
examin
possibl
investig
whether
purifi
viral
core
would
bind
microtubul
vitro
found
viral
core
abl
bind
microtubul
proteasetr
core
show
associ
figur
b
preincub
purifi
viral
core
antibodi
specif
inhibit
interact
viral
core
microtubul
figur
contrast
igg
antibodi
inhibitori
effect
figur
f
taken
togeth
data
suggest
maplik
properti
may
play
role
mediat
interact
incom
viral
core
microtubul
dramat
rearrang
microtubul
cytoskeleton
occur
vaccinia
infect
unlik
attribut
exclus
action
sinc
associ
subset
microtubul
figur
furthermor
loss
microtubul
organ
preced
detect
associ
microtubul
occur
h
postinfect
therefor
wonder
whether
vaccinia
infect
disrupt
centrosom
function
given
loss
microtubul
aster
configur
infect
figur
sinc
microtubul
nucleat
centrosom
anim
cell
examin
whether
vaccinia
infect
affect
critic
requir
process
stearn
kirschner
observ
label
centrosom
greatli
reduc
earli
h
postinfect
figur
result
obtain
infect
cell
stabli
express
green
fluoresc
protein
gfp
label
khodjakov
rieder
addit
centrosom
centriolar
compon
pericentrin
cnap
nek
centrin
reduc
immunofluoresc
centrosomescentriol
vacciniainfect
cell
figur
furthermor
reduct
centrosom
marker
requir
viral
protein
synthesi
level
affect
cell
infect
presenc
cycloheximid
data
shown
dramat
reduct
centrosom
impli
vaccinia
infect
perturb
centrosom
function
test
hypothesi
examin
whether
centrosom
vacciniainfect
cell
could
renucl
microtubul
follow
depolymer
nocodazol
found
h
postinfect
alreadi
see
reduct
microtubul
nucleat
centrosom
ineffici
compar
uninfect
control
indic
vaccinia
disrupt
normal
centrosom
function
figur
later
time
postinfect
microtubul
renucl
effici
centrosom
even
lower
data
shown
howev
follow
nocodazol
washout
microtubul
eventu
repolymer
throughout
cytoplasm
infect
cell
display
organ
mtoc
control
compar
figur
k
size
viru
particl
unlik
move
within
cell
diffus
alon
suggest
movement
requir
interact
host
cytoskeleton
previou
data
shown
vaccinia
viru
disrupt
hijack
actin
cytoskeleton
facilit
movement
intracellular
envelop
form
vaccinia
viru
cudmor
et
al
et
al
infect
cell
sanderson
smith
sanderson
et
al
data
describ
show
vaccinia
also
use
subsequ
disrupt
microtubul
cytoskeleton
infect
cycl
clear
experi
previou
observ
ulaeto
et
al
microtubul
requir
maintain
integr
golgi
apparatu
turn
requir
imv
wrap
form
iev
schmelz
et
al
contrast
imv
assembl
absenc
microtubul
albeit
reduc
level
microtubul
requir
imv
assembl
requir
togeth
complex
virion
accumul
vicin
microtubul
aster
one
envisag
minu
enddirect
microtubuledepend
movement
imv
particl
site
assembl
viral
factori
toward
mtoc
complex
would
enhanc
possibl
wrap
golgi
apparatu
subsequ
iev
format
recent
shown
imv
protein
microtubul
requir
effici
imv
dispers
viral
factori
sanderson
et
al
absenc
matur
imv
particl
accumul
peripheri
viru
factori
subsequ
wrap
form
iev
presum
unabl
move
microtubul
sanderson
et
al
microtubul
accumul
vaccinia
vicin
mtoc
analog
microtubuledepend
movement
requir
herp
simplex
viru
adenoviru
reach
site
replic
nucleu
sodeik
et
al
suomalainen
et
al
leopold
et
al
case
protein
associ
incom
nucleocapsid
interact
intermedi
chain
cytoplasm
dynein
ye
et
al
also
report
incom
nucleocapsid
pseudorabi
viru
alphaherp
viru
close
relat
associ
depend
microtubul
movement
nucleu
kaelin
et
al
interact
may
mediat
protein
minor
essenti
compon
capsid
coloc
microtubul
accumul
mtoc
kaelin
et
al
accumul
mtoc
consist
possibl
interact
motor
complex
known
local
mtoc
echeverri
et
al
would
surpris
base
observ
pseudorabi
microtubul
also
involv
establish
infect
cycl
cytomegaloviru
cmv
viru
varicellazost
viru
herp
virus
clear
exampl
microtubuledepend
viru
movement
establish
infect
incom
human
foami
viru
hfv
depend
microtubul
presum
minu
enddirect
microtubul
motor
get
nuclear
replic
site
saib
et
al
absenc
protein
express
hfv
gag
protein
associ
viral
genom
accumul
centrosom
microtubuledepend
fashion
prior
nuclear
import
saib
et
al
centrosom
accumul
gag
protein
hfv
howev
appear
uniqu
class
retrovirus
similar
local
report
human
immunodefici
viru
hiv
retrovirus
hand
gag
protein
murin
leukaemia
viru
hiv
shown
interact
microtubul
plu
enddirect
kinesin
motor
vitro
vivo
kim
et
al
tang
et
al
suggest
addit
role
may
exist
microtubul
motor
outward
movement
viru
particl
inde
vaccinia
viru
particl
abl
reach
cell
peripheri
absenc
actinbas
motil
see
imag
wolff
et
al
sanderson
et
al
et
al
suggest
viral
particl
also
move
microtubul
sanderson
et
al
microtubuledepend
motordriven
movement
viru
particl
repres
effici
mechan
achiev
perinuclear
local
requir
facilit
entri
nucleu
establish
infect
also
provid
excel
way
newli
assembl
viru
particl
reach
cell
peripheri
facilit
continu
spread
infect
data
show
although
vaccinia
viru
use
microtubul
cytoskeleton
achiev
perinuclear
local
microtubul
golgi
organ
becom
disrupt
later
infect
process
interestingli
cmv
also
report
disrupt
microtubul
cytoskeleton
golgi
organ
infect
cycl
avitabil
et
al
fish
et
al
disrupt
microtubul
network
might
first
sight
appear
benefici
viru
may
actual
hinder
viral
spread
could
enhanc
first
extens
viru
assembl
spread
cell
peripheri
alreadi
occur
time
microtubul
cytoskeleton
golgi
organ
disrupt
secondli
disrupt
microtubul
organ
may
overcom
potenti
microtubul
motor
anchor
effect
mtoc
thu
allow
viral
spread
peripheri
occur
easili
lastli
format
long
project
support
extens
microtubul
bundl
provid
mean
achiev
long
rang
spread
viru
particl
sanderson
et
al
clear
disrupt
reorgan
microtubul
cytoskeleton
vaccinia
viru
mediat
combin
effect
viral
protein
maplik
properti
loss
microtubuleorgan
function
mtoc
may
also
true
although
disrupt
centrosom
function
remain
establish
late
infect
microtubul
organ
bundl
around
nucleu
show
mtocorchestr
organ
avitabil
et
al
identif
viral
protein
maplik
properti
uniqu
vaccinia
viru
tegument
protein
coloc
microtubul
infect
cell
induc
microtubul
bundl
express
uninfect
cell
elliott
hare
exampl
viral
map
base
vivo
local
vitro
associ
microtubul
n
protein
murin
coronaviru
kalicharran
dale
movement
protein
tobamoviru
heinlein
et
al
aphid
transmiss
factor
cauliflow
mosaic
viru
blanc
et
al
protein
pseudorabi
viru
kaelin
et
al
spike
protein
rotaviru
nejmeddin
et
al
protein
vesicular
stomat
viru
vsv
melki
et
al
identif
two
viral
core
protein
maplik
protein
howev
unexpect
given
previous
character
role
viral
morphogenesi
vanslyk
hrubi
interact
microtubul
vivo
togeth
vitro
microtubulebind
data
suggest
potenti
mechan
associ
viral
core
microtubul
one
could
envisag
viral
core
releas
cytoplasm
begin
infect
ichihashi
vanderpasschen
et
al
pedersen
et
al
bind
directli
microtubul
manner
analog
adenoviru
nucleocapsid
work
requir
determin
whether
incom
core
fact
move
toward
mtoc
complex
andor
use
complex
anchor
microtubul
loss
centrosom
function
must
enhanc
disrupt
microtubul
cytoskeleton
infect
inde
loss
microtubul
organ
mtoc
preced
detect
associ
microtubul
occur
h
postinfect
vacciniainduc
loss
centrosom
protein
inhibit
cycloheximid
indic
viral
protein
express
requir
disrupt
centrosom
microtubul
nucleat
activ
knowledg
vaccinia
viru
infect
repres
first
exampl
virusinduc
disrupt
centrosom
function
although
would
predict
may
similar
effect
mechan
vaccinia
viru
disrupt
centrosom
requir
studi
nevertheless
clear
understand
molecular
basi
disrupt
provid
import
insight
regul
stabil
centrosom
function
current
subject
intens
research
ohta
et
al
lane
nigg
karsenti
hela
cell
atcc
infect
wildtyp
vaccinia
viru
strain
western
reserv
wr
vaccinia
delet
mutant
blasco
moss
parkinson
smith
multipl
infect
pfu
plaqueform
unit
per
cell
describ
previous
et
al
nocodazol
dissolv
dimethyl
sulfoxid
dmso
brefeldin
dissolv
ethanol
ad
cultur
medium
final
concentr
respect
unless
otherwis
state
nontreat
control
equal
volum
dmso
ethanol
ad
cell
transfect
myctag
express
construct
echeverri
et
al
infect
h
later
wr
subsequ
fix
h
postinfect
experi
describ
repeat
time
follow
antibodi
kindli
provid
dr
ekarsenti
anticentrin
professor
jlsalisburi
sander
salisburi
paoletti
et
al
professor
enigg
fri
et
al
b
antimyc
dr
tnilsson
et
al
antibodi
correspond
vaccinia
protein
professor
dhrubi
vanslyk
hrubi
professor
ptraktman
klemper
et
al
dr
mesteban
rodriguez
et
al
et
al
addit
follow
antibodi
obtain
commerci
sourc
amersham
intern
uk
antiacetyl
sigma
usa
sigma
antipericentrin
babco
usa
rabbit
igg
sigma
actin
visual
fluoresc
label
phalloidin
deriv
molecular
probe
usa
cell
fix
methanol
paraformaldehyd
mm
pipe
ph
mm
mm
egta
follow
triton
permeabil
fix
cell
process
immunofluoresc
view
imag
record
describ
previous
et
al
hela
cell
preincub
nocodazol
medium
h
depolymer
microtubul
prior
infect
vaccinia
pfucel
nocodazol
kept
medium
throughout
infect
equal
volum
dmso
ad
control
h
postinfect
cell
scrape
flask
medium
sediment
centrifug
g
min
cell
membran
disrupt
nuclei
remov
centrifug
result
postnuclear
supernat
centrifug
sucros
cushion
g
min
viru
pellet
resuspend
mm
tri
ph
viru
collect
centrifug
g
min
resuspend
mm
tri
ph
store
concentr
viru
element
bodi
determin
measur
joklik
purifi
eev
particl
prepar
describ
previous
et
al
subsequ
use
prepar
viru
core
follow
method
cudmor
et
al
rhodaminelabel
microtubul
prepar
accord
hyman
et
al
vaccinia
viru
core
incub
rhodaminelabel
microtubul
buffer
contain
taxol
min
room
temperatur
dapi
ad
subsequ
final
concentr
label
viru
core
final
mixtur
dilut
antifad
solut
mgml
catalas
mgml
glucos
oxidas
mm
glucos
view
without
fixat
proteinas
k
trypsin
treatment
core
particl
prior
incub
microtubul
perform
describ
previous
roo
et
al
control
igg
antibodi
incub
purifi
core
h
room
temperatur
prior
incub
microtubul
extract
hela
cell
infect
h
uninfect
control
maintain
presenc
mgml
rifampicin
prepar
describ
previous
et
al
extract
clarifi
centrifug
g
min
cytochalasin
ad
final
concentr
depolymer
actin
filament
endogen
tubulin
extract
polymer
twostep
procedur
first
extract
supernat
supplement
proteas
inhibitor
mm
mggtp
taxol
incub
min
room
temperatur
subsequ
addit
taxol
ad
mix
reaction
incub
min
control
taxol
ad
stage
microtubul
polymer
inhibit
either
addit
nocodazol
final
concentr
maintain
extract
throughout
experi
follow
microtubul
assembl
extract
reaction
dilut
buffer
contain
proteas
inhibitor
taxol
centrifug
sucros
cushion
contain
proteas
inhibitor
taxol
g
min
microtubul
pellet
solubil
sampl
buffer
analys
ingel
proteolyt
cleavag
perform
automat
progest
describ
houthaev
et
al
genom
solut
cambridg
http
wwwgenomicsolutionscom
peptid
obtain
analys
bruker
reflex
maldi
mass
spectromet
bruker
analytik
germani
jensen
et
al
protein
identifi
peptid
mass
fingerprint
jensen
et
al
use
pro
gram
peptidesearch
http
wwwnarradoremblheidelbergdeservicespeptidesearchpeptidesearchintrohtml
h
postinfect
nocodazol
ad
cultur
medium
final
concentr
depolymer
microtubul
h
postinfect
cell
wash
time
warm
medium
remov
nocodazol
wash
cell
incub
medium
without
nocodazol
indic
time
reiniti
microtubul
polymer
wash
briefli
warm
phosphatebuff
salin
pb
immedi
fix
parallel
sampl
also
remov
time
point
briefli
rins
icecold
pb
fix
process
immunofluoresc
confirm
complet
microtubul
depolymer
initi
microtubul
assembl
uninfect
control
hela
cell
treat
process
ident
fashion
number
imag
integr
use
ident
camera
set
allow
direct
comparison
infect
uninfect
sampl
experi
